Showing results (591-600 of 2,578) with videos related to

Sort By:
Pageof 258
Molecular Oncology|March 17, 2026
E2A selectively regulates TGF-β-induced apoptosis in KRAS-mutant non-small cell lung cancerSergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, et al.
Molecular Oncology|April 10, 2026
Revisiting Mission-Oriented Cancer Research to tackle the increasing burden of cancer in Europe-a policy perspectiveManuel Heitor, Julio Celis, Ulrik Ringborg
Molecular Oncology|May 6, 2026
Clinical performance of the urine-based TERT promoter AbsoluteQ Digital PCR for non-invasive detection of bladder cancerAnna Nykel, Izabela Kubiak, Lena Rutkowska, et al.
Molecular Oncology|March 19, 2026
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancerGabriela Marinescu, Yi Feng
Molecular Oncology|April 28, 2026
Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panelCarlos Casas-Arozamena, Karin Teien Lande, Eva Diaz, et al.
Molecular Oncology|June 5, 2026
Patient therapy outcome modeling in cancer organoids is improved by cancer-associated fibroblasts and organoid assembly convolutionMarcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, et al.
Molecular Oncology|June 8, 2026
Weakening the nuclear envelope: Lamin B receptor in melanoma metastasisFrancesca Lorenzini, Maria Caterina Mione
Molecular Oncology|May 28, 2026
Interpreting the effects of DNA polymerase variants at the structural levelMatteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, et al.
Molecular Oncology|May 27, 2026
Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinomaKamila J Bienkowska, Stephany Gallardo, Nur S Zainal, et al.
Molecular Oncology|June 6, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer modelLuisa Schwarzmüller, Janina Müller, Efstathios-Iason Vlachavas, et al.
Pageof 258